Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Abbott Laboratories Reports Strong Q3 Earnings, Stocks Prognosis Recommends Buying ABT Shares

November 26, 2024
Abbott Laboratories, a leading global healthcare company, has recently reported strong financial results for the third quarter of the year. The company's revenue increased by 9% compared to the same period last year, driven by solid performance across its business segments.

Abbott's medical devices division, which includes products such as cardiovascular devices and diabetes care, experienced a robust growth of 12%. The company's diagnostics division also saw significant growth, with a 7% increase in revenue.

These positive results can be attributed to Abbott's ongoing investment in innovation and expansion into emerging markets. The company has been focusing on developing advanced healthcare technologies and solutions to address the growing global demand for quality healthcare.

Stocks Prognosis, a leading investment analysis firm, recommends buying ABT shares based on the company's strong financial performance and promising growth prospects. With a solid track record and a strong presence in the healthcare industry, Abbott Laboratories is well-positioned to capitalize on the increasing demand for healthcare products and services.

Investors are advised to consult with professionals from Stocks Prognosis to get a comprehensive forecast of the future movement of ABT shares. Their expertise and analysis can help investors make informed decisions and potentially maximize their returns.

Disclaimer: This news article is not promoting the purchase or sale of ABT shares, but purely providing information about the company's recent financial performance and recommending professional consultation for investing decisions.
If you want to leave a comment, then you need Login or Register





Other data for ABT

Related data

ABTAugust 9, 2025Abbott Laboratories NYSE:ABT Earnings Are Of Questionable Quality  ~1 min.

Abbott Laboratories recently reported their second quarter 2025 earnings, with EPS exceeding expectations....


ABTJune 5, 2025Abbott Laboratories ABT is Attracting Investor Attention: Here is What You Should Know  ~1 min.

Abbott Laboratories (ABT) has been making waves in the healthcare sector, attracting attention from investors around the globe....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTMarch 17, 2025Abbott Laboratories: A Leader in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) is a renowned healthcare company that has caught the attention of investors and industry experts alike....


ABTMarch 16, 2025Abbott Laboratories: Breaking New Ground in Healthcare Innovation  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making waves in the healthcare industry with its groundbreaking innovations....


ABTMarch 15, 2025Abbott Laboratories: A Healthcare Stock With Long-Term Investment Potential  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has been delivering groundbreaking medical technologies and products for decades....


ABTFebruary 26, 2025Abbott Laboratories Continues to Deliver Strong Earnings Growth  ~2 min.

Abbott Laboratories, a leading global healthcare company, has reported steady growth in earnings over the past five years....


ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....


ABTFebruary 21, 2025Abbott Laboratories NYSE:ABT: A Leading Drug Stock with Promising Future  ~1 min.

Abbott Laboratories, a renowned pharmaceutical company, has emerged as one of the best drug stocks to invest in....


ABTFebruary 21, 2025ABBOTT LABORATORIES Stock Hits Price Target with 16.11% Profit: QuantWave Forecast Success  ~2 min.

On December 2, 2024, QuantWave, the automated forecasting platform, issued a long signal for ABBOTT LABORATORIES stock when it was trading at 115.66 $....


ABTJanuary 2, 2025Abbott Laboratories: A Promising Stock with Strong Fundamentals  ~2 min.

Abbott Laboratories (NYSE:ABT) is catching the attention of investors, including Diamond Hill Capital, as one of their top stock picks....


ABTDecember 9, 2024Abbott Laboratories: Revolutionizing Healthcare with Innovative Solutions  ~2 min.

Abbott Laboratories (ABT) is making waves in the healthcare industry with its groundbreaking innovations and commitment to improving lives....


ABTNovember 25, 2024Abbott Laboratories: A Leading Company in Healthcare  ~2 min.

Abbott Laboratories (NYSE:ABT) is a renowned healthcare company that has gained significant attention from investors....


ABTMarch 18, 2025Abbott Laboratories Continues to Drive Growth in the Healthcare Sector  ~2 min.

Abbott Laboratories (ABT) has emerged as a top player in the healthcare industry, making it an attractive stock for long-term investors....


ABTDecember 2, 2024Abbott Laboratories Continues to Expand its Global Footprint  ~2 min.

Abbott Laboratories (NYSE: ABT), a global healthcare company, has been making significant strides in its efforts to expand its operations worldwide....